Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.50
Bid: 35.50
Ask: 36.50
Change: -0.50 (-1.39%)
Spread: 1.00 (2.817%)
Open: 36.00
High: 35.50
Low: 35.50
Prev. Close: 36.00
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

1 Aug 2018 13:24

RNS Number : 5083W
Creo Medical Group PLC
01 August 2018
 

1 August 2018

Creo Medical Group plc

("Creo" or the "Company")

 

Result of General Meeting

 

Creo Medical Group plc (AIM: CREO) is pleased to announce that, at the General Meeting held today, all resolutions were duly passed by means of a poll vote. The total number of votes received for each resolution is set out below:

 

Resolution No.

Votes for

Votes against

Votes total

Votes withheld

01

63,639,528 (94.09%)

 

3,995,278 (5.91%)

67,634,806 (83.37%)

625,000

02

63,639,528 (94.09%)

 

3,995,278 (5.91%)

67,634,806 (83.37%)

625,000

03

63,639,528 (93.23%)

4,620,278 (6.77%)

68,259,806 (84.14%)

 

0

 

The Company confirms that, conditional on Admission becoming effective, it has allotted and issued 4,000,000 new Ordinary Shares pursuant to the EIS/VCT Placing. It is expected that the EIS/VCT Placing Shares will be admitted to AIM with effect from 8.00am tomorrow, 2 August 2018.

 

Further details regarding the Placing and the Placing Shares can be found in the announcement issued by the Company on 13 July 2018 and in the Circular posted to Shareholders on that same day, which are available to view on the Company's website: investors.creomedical.com. Capitalised terms used, but not defined, in this announcement shall have the same meaning as set out in the Circular.

 

Following Admission of the EIS/VCT Placing Shares, the Company's issued ordinary share capital will consist of 85,123,065 Ordinary Shares; no shares are held in treasury. The above figure of 85,123,065 Ordinary Shares may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Additional EIS/VCT Placing is conditional on receipt of the Additional VCT Advanced assurance by the Company. Whilst the Non EIS/VCT Placing is not conditional the receipt of the Additional VCT Advanced Assurance, the allotment and Admission of the Non EIS/VCT Shares cannot take place before the allotment of the Additional EIS/VCT Shares.

 

As the Additional VCT Advanced Assurance has not yet been obtained, the issue of the Additional EIS/VCT Shares and the Non EIS/VCT Shares has been delayed. Admission of the Additional EIS/VCT Shares and Non EIS/VCT Shares will occur on the third Business Day following receipt of Additional VCT Advanced Assurance.

 

In the event that the Additional VCT Advanced Assurance is not received before the Long Stop Date of 13 September 2018 (or at such time as HMRC has informed the Company that such approval will not be obtained), then the Additional EIS/VCT Placing will not complete, but the Non EIS/VCT Placing will complete, the Non EIS/VCT Shares will be issued and Admission of the Non EIS/VCT Shares will take place at latest on the Long Stop Date.

 

Contacts

 

Creo Medical:

+44 (0)129 160 6005

Richard Rees

Cenkos:

+44 (0)207 397 8900

Camilla Hume / Mark Connelly (NOMAD)

Michael Johnson / Russell Kerr (Sales)

FTI Consulting:

+44 (0)203 727 1000

Brett Pollard / Mo Noonan

creo@fticonsulting.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMSSEFEFFASEEA
Date   Source Headline
28th Sep 20187:00 amRNSInterim results for six months ended 30 June 2018
17th Sep 20187:04 amRNSExtension of Distribution Agreement with Pentax
13th Sep 20187:00 amRNSFirst use of Speedboat in South Africa
3rd Sep 20181:34 pmRNSHolding(s) in Company
31st Aug 201811:32 amRNSHolding(s) in Company
31st Aug 201811:30 amRNSDirector/PDMR Shareholding
21st Aug 20183:59 pmRNSIssue of Equity Update - Amendment
21st Aug 20181:48 pmRNSIssue of Equity Update
20th Aug 201810:13 amRNSDirector/PDMR Shareholding
1st Aug 20181:24 pmRNSResult of General Meeting
18th Jul 20184:44 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSConditional Placing of New Ordinary Shares
9th Jul 20187:00 amRNSAgreement with First Medical Company
4th Jul 20187:00 amRNSUK Distribution Agreement with Diagmed Healthcare
2nd Jul 20187:00 amRNSMarket Update
10th May 201811:25 amRNSExercise of Options
20th Apr 20184:38 pmRNSChange of accounting reference date
20th Mar 20187:00 amRNSInterim results for six months to 31 December 2017
28th Feb 20184:32 pmRNSChange of Registered Office
12th Feb 20187:00 amRNSExercise of Options
9th Jan 20185:43 pmRNSDirector/PDMR Shareholding
22nd Dec 201712:10 pmRNSDirector/PDMR Shareholding
22nd Dec 20179:24 amRNSDirector/PDMR Shareholding
20th Dec 20171:32 pmRNSResult of AGM
29th Nov 20177:00 amRNSSpeedboat RS2 advances beyond initial pilot centre
24th Nov 201710:49 amRNSNotice of AGM
14th Nov 20177:00 amRNSFinal Results
25th Sep 20173:07 pmRNSHolding(s) in Company
18th Sep 20179:56 amRNSHolding(s) in Company
11th Sep 20172:05 pmRNSChange of Registered Office
1st Sep 20179:42 amRNSHolding(s) in Company
21st Aug 20177:00 amRNSAnnounces US FDA Approval of Speedboat RS2
29th Jun 20177:00 amRNSCreo Medical Pre-Submission 510k Confirmation
22nd Jun 20177:00 amRNSAnnounces First Patient Treated with Speedboat
4th Apr 20175:47 pmRNSDirector/PDMR Dealing
30th Mar 20177:00 amRNSCreo Medical Interim Results
24th Mar 20177:00 amRNSCreo CE Mark for microwave for Speedboat RS2
1st Mar 20177:00 amRNSAnnounces Participation in Research Programme
2nd Feb 20177:21 amRNSDirector/PDMR Shareholding
9th Dec 20167:00 amRNSCreo First Day of Dealings on AIM
17th Jun 20107:00 amRNSCity Centre Development
16th Jun 20104:00 pmRNSScheme of arrangement re Court Hearing
16th Jun 20107:00 amRNSSuspension - China Real Estate Opportunities Plc
9th Jun 201012:00 pmRNSResult of AGM
7th Jun 20101:03 pmRNSResult of EGM & Court Meeting
21st May 20107:00 amRNSPosting of Scheme Document
4th May 20104:00 pmRNSPublication of Financial Accounts
26th Apr 20107:00 amRNSUpdate on Proposed Asian Listing
26th Mar 20104:35 pmRNSShareholder notification
25th Mar 20103:10 pmRNSSale of CREO shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.